|
TW201321000A
|
|
Methods for treating a stroke-related sensorimotor impairment using aminopyridines
|
|
AU2004247021A1
|
|
Compositions and methods including a recombinant human MAB that promotes CNS remyelination
|
|
WO2004082684A1
|
|
Stable oral formulations of aminopyridines and uses thereof
|
|
WO0050447A1
|
|
Carbohydrate epitope mimic peptides and uses thereof
|
|
EP1159294A1
|
|
Carbohydrate epitope mimic peptides and uses thereof
|
|
WO9911796A1
|
|
Hnk-1 sulfotransferase and methods of use therefor
|
|
US6576607B1
|
|
Methods using CNS neurite outgrowth modulators
|
|
WO9856404A1
|
|
Cns neuroregenerative compositions and methods of use
|
|
CA2218599A1
|
|
Cns neurite outgrowth modulators, and compositions, cells and methods embodying and using same
|
|
CN1187774A
|
|
CNS neurite out growth modulators, and compositions, cells and methods embodying and using same
|
|
US5792743A
|
|
Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
|
|
US6750196B1
|
|
Methods of treating disorders of the eye
|
